Aevis Victoria SA

Swiss Stock Exchange AEVS.SW

Aevis Victoria SA Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 42.24 M

Aevis Victoria SA Net Cash Used For Investing Activities is USD 42.24 M for the year ending December 31, 2023, a 168.75% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Aevis Victoria SA Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -61.44 M, a -359.14% change year over year.
Aevis Victoria SA Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 23.71 M, a 107.06% change year over year.
Aevis Victoria SA Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -335.65 M, a -233.69% change year over year.
Aevis Victoria SA Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD 251.07 M, a 371.88% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Swiss Stock Exchange: AEVS.SW

Aevis Victoria SA

CEO	Mr. Fabrice Zumbrunnen
IPO Date	July 12, 2001
Location	Switzerland
Headquarters	Rue Georges-Jordil 4
Employees	4,033
Sector	Healthcare
Industries Hospitals & Clinics Dental Care Drugstores & Retail Pharmacies Hospitality Hotels Restaurants Senior Care Telehealth

Description

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

Key trends

Past 5 years